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Introduction: The Abernethy malformation is a rare anomaly with a widely variable clinical presentation. Many
diagnostic dilemmas have been reported. Nowadays, with the evolution of medical imaging, diagnosis can be
made more easily, but management of patients with an Abernethy malformation is still open for discussion.
Case presentation: In this case study, we describe a 34-year-old Caucasian man who presented with a large
hepatocellular carcinoma in the presence of an Abernethy malformation, which was complicated by the
development of pulmonary arterial hypertension.
Conclusion: This case underlines the importance of regular examination of patients with an Abernethy
malformation, even in older patients, to prevent complications and to detect liver lesions at an early stage.
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The Abernethy malformation is an extremely rare anom-
aly of the splanchnic venous system. It is named after
John Abernethy, who first reported the anomaly in 1793.
He described a portocaval shunt completely bypassing
the liver after a postmortem examination of a 10-
month-old girl [1]. Over 80 cases have been described
since, mostly in patients ages 18 years and younger [2,3].
The Abernethy malformation is divided into two types.
The described cases in the literature often refer to
patients with a type I malformation, which is an anomaly
defined by an absence of intrahepatic portal veins, thus
lacking liver perfusion with portal blood. Type I anomal-
ies may be further divided into subtypes A and B,
defined as the superior mesenteric and splenic veins
draining separately into the inferior caval vein in type IA
and draining from a common trunk in type IB [3]. A
type II shunt is defined as a malformation of the portal
vein leading to perfusion of the liver via a partial shunt.
Earlier case reports focused on the widely variable
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reproduction in any medium, provided the orencountered in diagnosing the malformation [2]. In re-
cent decades, portosystemic shunts have been recog-
nized more frequently because of the evolution and
expansion of medical imaging. Early recognition of a
portosystemic shunt is important, given the detrimental
effects of shunting on the liver and on the other organs
over the long term. In addition, it has been described
that liver lesions may develop during childhood. These
liver lesions may consist of benign tumors such as focal
nodular hyperplasia, hepatocellular adenoma or nodular
regenerative hyperplasia. Malignant lesions such as
hepatocellular carcinoma (HCC) also can develop, how-
ever, and they are most often described in patients with
a type I shunt [3-6].
We present the case of a 34-year-old man who was
diagnosed with the Abernethy malformation type II
three years before a large HCC was treated successfully.
Case presentation
A 34-year-old Caucasian man was referred to our hos-
pital with complaints of abdominal pain in the right
upper quadrant and pain in his right shoulder. The pain
was not associated with nausea or vomiting, and there
was no history of fever or jaundice.
His medical history included an open ductus venosus
and an Abernethy malformation complicated by thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Magnetic resonance angiography showing
hepatocellular carcinoma and a portocaval shunt.
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pulmonary artery pressure 48mmHg), which had been
diagnosed three years before and treated successfully
with the endothelin receptor antagonist bosentan. At the
time of presentation, he was in New York Heart Associ-
ation functional class I. Physical examination displayed
no signs of icterus, and cardiac examination revealed a
hyperkinetic cardiac impulse outside the midclavicular
line and a loud second heart sound. He had a soft abdo-
men without organomegaly. His laboratory test showed
a hemoglobin level of 9.2mmol/L, an elevated liver en-Figure 2 The portocaval shunt peri-operatively.zyme profile with aspartate aminotransferase 46U/L, ala-
nine aminotransferase 50U/L and bilirubin 32μmol/L. α-
Fetoprotein (AFP) concentration was normal (3μg/L) as
was hepatic synthetic function.
Computed tomography (CT) displayed the presence of
a tumor, and magnetic resonance imaging (MRI) was
performed for characterization of the lesion. The lesion
was hypointense on T1-weighted images and hyperin-
tense on T2-weighted images in the venous phase, and
arterial enhancement and washout were demonstrated,
as is typical for a HCC (Figure 1). The presence of a
shunt of 2 cm between the left extrahepatic portal vein
and the inferior vena cava was confirmed (Figures 2 and
3). Preoperatively, workup included several tests, such as
lung capacity (lung function test), cardiac function (elec-
trocardiogram) and hepatic synthetic function (labora-
tory tests). If the results of these tests were normal, the
patient would be eligible for surgery. In the preoperative
workup, no biopsy of the tumor neither a biopsy of the
normal liver parenchyma was found necessary. Because
of his pulmonary hypertension, he was categorized as an
American Society of Anesthesiologists (ASA) class 3 pa-
tient. There were no other contraindications for surgery,
and the patient underwent a successful right hemihepa-
tectomy and surgical discontinuation of the portocaval
shunt. Postoperatively, his pulmonary hypertension
increased, and he needed oxygen for five days, after which
his condition recovered. Furthermore, a small biloma was
diagnosed, which was treated by percutaneous drainage.
Histological examination of the resected specimen
revealed features of grade II fibrosis [7]. A tumor with a
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Figure 3 The portocaval shunt peri-operatively.
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presence of microvascular invasion. A tumor-free surgi-
cal resection of 5mm was recorded.
The follow-up of the patient consisted of a routine
serum tumor marker AFP determination and contrast-
enhanced CT or MRI at six months intervals starting
three to six months after surgery. After nearly two years
of follow-up, the patient is doing well and is free of
HCC recurrence. His cardiac output is normalized, and
his pulmonary hypertension is stable.
Discussion
Treatment of congenital malformations of the portal sys-
tem depends on the type of portocaval fistulas, the pre-
senting symptoms, complications and comorbidity.
Treatment may vary from surgical correction of the
shunt to even liver transplantation [8].
Patients with the Abernethy malformation have been
described in several case reports, most (80%) of them in-
volving children ages 18 years and younger [2,3]. Man-
agement strategies for children with a type I shunt have
been developed, with close monitoring of clinical, bio-
chemical and radiological parameters in follow-up being
advocated [4]. When an Abernethy malformation is
detected, surgical closure of the shunt should beconsidered. If the shunt cannot be closed, then the pa-
tient should be carefully followed.
To date, no management strategy has been described
for adult patients with a type II shunt. We propose regu-
lar follow-up of patients with a type II shunt as well. Ab-
sence of a decent portal circulation and systemic
diversion of portal vein flow may have consequences for
hepatic development, function and regenerative capacity,
thus predisposing such patients to the development of fi-
brosis, nodular dysplasia or HCC.
Although it has long been considered that essentially
all HCCs arise from cirrhotic changes, recent reports
have indicated that they can occur in 40% of the patients
without cirrhosis of chronic liver disease such as that in
our patient [9].
Patients infected with hepatitis B or patients with cir-
rhosis due to hepatitis C virus infection, alcohol abuse
or another cause are patients at risk for the development
of HCC. These patients are encountered in a surveil-
lance program. The patients at risk are screened at six to
12 months intervals using liver ultrasonography and
serum AFP levels [10]. In cases of abnormal findings,
more appropriate follow-up and management can lead
to early detection of potentially malignant dysplastic
lesions. In our patient, the tumor was large at diagnosis.
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sidual liver tissue, which made a liver resection (hemihe-
patectomy right) technically possible, although it was
risky in this particular case because of the size of the
tumor with regard to the radicality of the resection.
Liver resections of large malignant tumors have been
described before [11]. In cases of a small tumor, patients
can be treated with curative intention more often, and
five years survival rates over 70% can be achieved [4].
Conclusion
This case underlines the importance of regular examin-
ation of patients with an Abernethy malformation, even
in older patients, to prevent complications and to detect
liver lesions at an early stage.
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